Satsuma Pharmaceuticals, Inc. - Common stock (NQ:STSA)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Jun 7, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Satsuma Pharmaceuticals, Inc. - Common stock

< Previous 1 2 3 Next >

Silver Rises Over 1%; Tyson Foods Posts Downbeat Earnings ↗

November 14, 2022

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite dropping around 60 points on Monday.

Via Benzinga

Why Is Satsuma Pharmaceuticals (STSA) Stock Down 80% Today? ↗

November 14, 2022

STSA stock is dropping after Satsuma Pharmaceuticals reported that its lead migraine drug candidate failed to meet expectations.

Via InvestorPlace

US Stocks Mostly Lower; Nasdaq Drops Over 100 Points ↗

November 14, 2022

U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping more than 100 points on Monday.

Via Benzinga

Satsuma Pharma Shares Nosedives After Disappointing Data From Migraine Study ↗

November 14, 2022

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 14, 2022

Gainers Opiant Pharma (NASDAQ:OPNT) stock rose 118.3% to $20.74 during Monday's pre-market session. The market value of their outstanding shares is at $107.1 million. As per the press release, Q3...

Via Benzinga

Expert Ratings for Satsuma Pharmaceuticals ↗

October 10, 2022

Satsuma Pharmaceuticals (NASDAQ:STSA) has observed the following analyst ratings within the last quarter:

Via Benzinga

This Stock Earns Price Bump, Bullish Pitch On Recent Positive Migraine Drug Data ↗

September 21, 2022

Via Benzinga

Satsuma Pharma Shares Are Gaining After Encouraging Update From Migraine Candidate ↗

September 20, 2022

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 12, 2022

Gainers Adamis Pharmaceuticals (NASDAQ:ADMP) shares moved upwards by 28.1% to $0.19 during Wednesday's pre-market session. The market value of their outstanding shares is at $28.1 million.

Via Benzinga

Why Immunic Shares Jumped By Around 57%; Here Are 73 Biggest Movers From Yesterday ↗

October 11, 2022

Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares climbed 71% to close at $2.12 on Monday after the company announced it has received its largest single purchase order for LinearDNA™ valued...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 10, 2022

Gainers

Via Benzinga

Why Applied DNA Sciences Shares Are Trading Higher By Around 65%, Here Are 54 Stocks Moving In Monday's Mid-Day Session ↗

October 10, 2022

Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares jumped 64.5% to $2.03 after the company announced it has received its largest single purchase order for LinearDNA™ valued above the...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2022 ↗

October 10, 2022

Upgrades

Via Benzinga

This Analyst Boosts Price Target On Satsuma Pharmaceuticals By 200%? Plus UBS Predicts $38 For General Motors ↗

October 10, 2022

SVB Leerink raised the price target on Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA) from $5 to $15. SVB Leerink analyst Marc Goodman upgraded the stock from Market Perform to Outperform. Satsuma...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 20, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 31, 2022 ↗

August 31, 2022

Upgrades

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022 ↗

August 25, 2022

Upgrades

Via Benzinga

Why Quoin Pharmaceuticals Plunged Over 62%; Here Are 120 Biggest Movers From Friday ↗

August 08, 2022

Gainers

Via Benzinga

Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary ↗

August 02, 2022

Via Benzinga

This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday ↗

June 28, 2022

Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade.

Via Benzinga

5 Biotech Stocks To Watch During The Week Of June 13 ↗

June 13, 2022

Biotech stocks continued to be under pressure in the past week amid broader market weakness, precipitated by economic worries. Company-specific developments also triggered downward moves. Here's a...

Via Benzinga

Mizuho Remains Bullish On This Small-Cap Stock's Migraine Candidate, But Why Did It Cut Price Target ↗

May 13, 2022

Mizuho Securities says that the Satsuma Pharmaceuticals Inc (NASDAQ: STSA) story is essentially unchanged. It remains bullish on STS101's potential as an effective, safe, and reliable intranasal...

Via Benzinga

The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy ↗

April 06, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

The Week Ahead In Biotech (April 3-April 9): BioXcel FDA Decision, Neurology Conference Presentations Take The Spotlight ↗

April 03, 2022

Biopharma stocks outperformed the broader market in the week ending April 2, thereby recouping the losses from the previous week. Clinical readouts and FDA decisions were among the chief catalysts that...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

April 01, 2022

On Friday, 111 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was Citigroup (...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 16, 2022

Gainers

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

March 09, 2022

During Wednesday's session, 35 companies made new 52-week lows. 52-Week High And Low Highlights: The company with the largest market cap to set a new 52-week low was...

Via Benzinga

3 Stocks Insiders Are Buying ↗

October 22, 2021

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go...

Via Benzinga

The Daily Biotech Pulse: Novavax Retreats Amid Vaccine Issues, LumiraDx COVID Test Approved In India, Sesen Shines On Positive Bladder Cancer Review ↗

October 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Novavax Shares React to Reports Of Manufacturing Issues With Its COVID-19...

Via Benzinga

40 Biggest Movers From Yesterday ↗

October 07, 2021

Gainers Volcon, Inc. (NASDAQ: VLCN) shares jumped 97.5% to settle at $10.86 on Wednesday as the company priced its IPO at $5.50 per share. Voyager Therapeutics, Inc. (NASDAQ:...

Via Benzinga

Topics Initial Public Offering

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.